These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27237318)

  • 61. Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells.
    Shah T; Krishnamachary B; Wildes F; Wijnen JP; Glunde K; Bhujwalla ZM
    NMR Biomed; 2018 Aug; 31(8):e3936. PubMed ID: 29928787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription.
    Deng B; Zhang S; Zhou Y; Sun T; Zhu Y; Fei J; Li A; Miao Y
    Cancer Cell Int; 2024 Jul; 24(1):237. PubMed ID: 38971758
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surface plasmon resonance microscopy identifies glycan heterogeneity in pancreatic cancer cells that influences mucin-4 binding interactions.
    Aguilar Díaz de León JS; Thirumurty M; Ly N
    PLoS One; 2024; 19(5):e0304154. PubMed ID: 38776309
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
    Guda K; Moinova H; He J; Jamison O; Ravi L; Natale L; Lutterbaugh J; Lawrence E; Lewis S; Willson JK; Lowe JB; Wiesner GL; Parmigiani G; Barnholtz-Sloan J; Dawson DW; Velculescu VE; Kinzler KW; Papadopoulos N; Vogelstein B; Willis J; Gerken TA; Markowitz SD
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12921-5. PubMed ID: 19617566
    [TBL] [Abstract][Full Text] [Related]  

  • 65. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers.
    Lin WR; Yeh CT
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Retracted: RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1.
    Markers D
    Dis Markers; 2023; 2023():9872910. PubMed ID: 37502578
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Workshop on Cell and Molecular Biology of Pancreatic Cancer. Proceedings. Madrid, Spain, November 16-18, 1992.
    Int J Pancreatol; 1993 Aug; 14(1):47-93. PubMed ID: 8105003
    [No Abstract]   [Full Text] [Related]  

  • 68. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection.
    Li Z; Yamada S; Wu Y; Wang KY; Liu YP; Uramoto H; Kohno K; Sasaguri Y
    Oncotarget; 2016 Aug; 7(34):54463-54473. PubMed ID: 27276675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. GALNT6 suppresses progression of colorectal cancer.
    Duan J; Chen L; Gao H; Zhen T; Li H; Liang J; Zhang F; Shi H; Han A
    Am J Cancer Res; 2018; 8(12):2419-2435. PubMed ID: 30662801
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of GALNT16 polymorphisms to breast cancer risk in Chinese population.
    Wu H; He G; Song T; Zhang Y; Chen X; Chen H; Xiong W; Sun C; Zhao C; Chen Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e848. PubMed ID: 31286696
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
    Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
    Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glycosyltransferase Gene Expression Identifies a Poor Prognostic Colorectal Cancer Subtype Associated with Mismatch Repair Deficiency and Incomplete Glycan Synthesis.
    Noda M; Okayama H; Tachibana K; Sakamoto W; Saito K; Thar Min AK; Ashizawa M; Nakajima T; Aoto K; Momma T; Katakura K; Ohki S; Kono K
    Clin Cancer Res; 2018 Sep; 24(18):4468-4481. PubMed ID: 29844132
    [No Abstract]   [Full Text] [Related]  

  • 73. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition.
    Lin J; Chung S; Ueda K; Matsuda K; Nakamura Y; Park JH
    Neoplasia; 2017 Jan; 19(1):43-53. PubMed ID: 28110670
    [TBL] [Abstract][Full Text] [Related]  

  • 74. GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8
    Sun X; Wu H; Tang L; Al-Danakh A; Jian Y; Gong L; Li C; Yu X; Zeng G; Chen Q; Yang D; Wang S
    Cancer Cell Int; 2024 Sep; 24(1):308. PubMed ID: 39245709
    [TBL] [Abstract][Full Text] [Related]  

  • 75. N-acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression.
    Sun L; Li Z; Shu P; Lu M
    Cancer Sci; 2024 Oct; 115(10):3320-3332. PubMed ID: 39105355
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pan-Cancer Analysis of GALNT6 with Potential Implications for Prognosis and Tumor Microenvironment in Human Cancer Based on Bioinformatics and qPCR Verification.
    Shao Y; Li R; Chen G; Zhang L
    Int J Gen Med; 2024; 17():2187-2201. PubMed ID: 38770365
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Performance Evaluation of The Random Forest Algorithm for A Gene Selection in Identifying Genes Associated with Resectable Pancreatic Cancer in Microarray Dataset: A Retrospective Study.
    Rabiei N; Soltanian AR; Farhadian M; Bahreini F
    Cell J; 2023 May; 25(5):347-353. PubMed ID: 37300296
    [TBL] [Abstract][Full Text] [Related]  

  • 78. GALNT6 Knockdown Inhibits the Proliferation and Migration of Colorectal Cancer Cells and Increases the Sensitivity of Cancer Cells to 5-FU.
    Peng X; Chen X; Zhu X; Chen L
    J Cancer; 2021; 12(24):7413-7421. PubMed ID: 35003361
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.